Business Forum PartneringDoing it right

Deal phases

Source: Thomson Reuters Cortellis

0.0%

5.0%

10.0%

15.0%

20.0%

25.0%

30.0%

35.0%

40.0%

45.0%

50.0%

% of development/commercialization deals by highest phase at deal startMay 2012 - May 2014

Preclinical deals

0.0%

5.0%

10.0%

15.0%

20.0%

25.0%

30.0%

35.0%

% of pre-clinical development/commercialization deals by therapeutic areaMay 2012 - May 2014

Source: Thomson Reuters Cortellis

Phase 1 deals

Source: Thomson Reuters Cortellis

0.0%

5.0%

10.0%

15.0%

20.0%

25.0%

% of phase 1 development/commercialization deals by therapeutic area May 2012 - May 2014

Phase 2 deals

Source: Thomson Reuters Cortellis

0.0%

2.0%

4.0%

6.0%

8.0%

10.0%

12.0%

14.0%

16.0%

18.0%

20.0%

% of phase 2 development/commercialization deals by therapeutic areaMay 2012 - May 2014

Phase 3 deals

Source: Thomson Reuters Cortellis

0.0%

5.0%

10.0%

15.0%

20.0%

25.0%

30.0%

% of phase 3 development/commercialization deals by therapeutic areaMay 2012 - May 2014